Maximum quantity allowed is 999
请选择数量
CAS RN: 24386-93-4 | 產品號碼: I1156
產品號碼 | I1156 |
純度/分析方法 | >98.0%(T)(HPLC) |
分子式 / 分子量 | C__1__1H__1__3IN__4O__4 = 392.15 |
外觀與形狀(20°C) | Solid |
儲存條件 | Refrigerated (0-10°C) |
儲存在惰性氣體下 | Store under inert gas |
應避免的情況 | Air Sensitive,Heat Sensitive |
CAS RN | 24386-93-4 |
Reaxys-RN | 4543232 |
MDL編號 | MFCD00055131 |
產品規格
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Volumetric Analysis) | min. 98.0 % |
NMR | confirm to structure |
性質
Maximum Wavelength | 284 nm (MeOH) |
GHS
相關法規
運輸資料
HS編碼* | 2934.99-000 |
Application
5-Iodotubercidin: A General Protein Kinase Inhibitor
5-Iodotubercidin is a potent and competitive adenosine protein kinase inhibitor. It has been reported that 5-iodotubercidin inhibits CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2, PKC, and nucleoside transporter.1-3) 5-iodotubercidin also inhibits LRRK2 (Leucine-rich repeat kinase 2) –G2019S that is a promising therapeutic target for the treatment of Parkinson's disease.4) There is a recent report, that 5-Iodotubercidin inhibits SARS-CoV-2 RNA-dependent RNA polymerase (RdRp).5) (The product is for research purpose only.)
References
- 1) Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor
- 2) Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT MF-2 smooth muscle cells
- 3) Adenosine Kinase Inhibitors. 1. Synthesis, Enzyme Inhibition, and Anti-seizure Activity of 5-Iodotubercidin Analogue
- 4) Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
- 5) 5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis
TCIMail
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。